ESQ vs REGN · P/E 18, $933.8M cap vs P/E 14, rev $4.29B
Esquire Financial Holdings Inc (ESQ) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Esquire Financial Holdings Inc (ESQ) is a banks - regional company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
ESQ does not have a complete income-statement cache yet.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ESQ currently screens at market cap $933.8M and trailing P/E 18.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ESQ and REGN stock pages for the full models.
Not investment advice.